Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
carboplatin (paraplatin) (1 trial)
paclitaxel (taxol) (1 trial)
Uterine Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)